In terms of diabetic complications, a JAK1 inhibitor baracitinib has been shown to protect the kidney from T2DM-induced albuminuria [22], highlighting a role for JAK1 in diabetes-induced vascular barrier dysfunction. The gene discussed is JAK1; the disease is diabetes mellitus.